{"name":"Pardes Biosciences, Inc.","slug":"pardes-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"endpoints.news","summary":"IPO Tracker (2021) - endpoints.news","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBYSmY3ZWJDOFduUkJqcmNYV2R6Rzc1YU9VVi1QcHZ2NW5mVXlWRVRocGYydmw1ZDNiSmpFSk9KcGVPQm8tTXRmRzF4YnAzRTFVcF9vYmZ6dkJmLXMwNmszMW96RTdtMFlacFloODUwSFpyV2VhbWd3?oc=5","date":"2023-12-22","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech M&A Tracker 2023: BMS, AbbVie drop billions for neuropsychiatry biotechs - Fierce Biotech","headline":"Fierce Biotech M&A Tracker 2023: BMS, AbbVie drop billions for neuropsychiatry biotechs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPdG1nZjdIS1FoQnozY0NUZGk3VE5YTm1vV3ZCcEM4bjBUaWFjYkxlb2FvNVBDM2dmYVZXR0lsZ3RCNERzQVRtWlhtVnFzemVKRVJjUkp1Nzh4YnVhNVRBNDVrZVBDOVZ5cjhvRkJlVDdxekRkZ3VZMEkwTlgtUktsQWJMWkllWllsSm1yYmpWV2MwVmpCbXM1OEpPc3YzMlNQTHV4N3BHbGJfWjdBcWFWNG85eS02cjFIeF9UU0JOYkZMLWJSeXpMYU1DT1l2TTdka0dGX0VGZG9UUi1qdU1GQUFoZFZhWTZiVWY5REdHMjdWVk01bC1POWtDSGM2X2FqUzZicWFNWQ?oc=5","date":"2023-08-28","type":"pipeline","source":"Business Wire","summary":"MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences - Business Wire","headline":"MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPa3RGUWlRV01GTzFPbDE3VXZsamZoZzBuVVRGMkFwVzJNRU52dmRLNEZLOUU0ckc2bm11c25YTTdIVmkxSHdDV0Y5a20yTlVFSlZmN294YzhzMlVpSEU4ZnJ5NlEySlRXQmRNTmNpemJLdEpneldrVkJHUlR0VjJKZVJjWEFSUGZ2MTVGeG5R?oc=5","date":"2023-07-17","type":"trial","source":"Fierce Biotech","summary":"Pardes Biosciences changes hands (sort of) in wake of COVID-19 trial fail - Fierce Biotech","headline":"Pardes Biosciences changes hands (sort of) in wake of COVID-19 trial fail","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNWEMtaGJfSmhsZ2wwMkFaTms2QlY4bnNZNVY4YlQxazZPb2RPODlKd0RBSkNtdDVmQnQ3dTZjd01CaVZHWDBlTW9DM19DYXl6dUdQVWRSdFlPWDB2WG5mQzAxRE1IdE8zdWc0UkFPOUdNVUtYSHZXZWxDdnNhcHJtUmdZQlVIM3hy?oc=5","date":"2023-05-29","type":"pipeline","source":"OpenSecrets","summary":"Pharmaceuticals/Health Products Lobbying Profile - OpenSecrets","headline":"Pharmaceuticals/Health Products Lobbying Profile","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQQi1qWXZtcjNhcHR6OGZZS0RPaV8zME9YVTFzVzF0NXVmMzN2NFcxcHEzaGZub2RUQjBXTFB2aWNuUm8weWlVaTV0SEhVSjdHc2lWWTlRb3NNRGt1dlhBSUZTOWpyRVR4UURIa3prUG92ZzBQSHhXVk1mRW10MjJCbzRCWWttcDkya0FhUmxsSm9PRGxGYWV1RDNORndINlhGb0dlUQ?oc=5","date":"2022-12-08","type":"pipeline","source":"The Pharma Letter","summary":"Mammoth Bio hires CBO and GC, adapting “big pharma” playbook - The Pharma Letter","headline":"Mammoth Bio hires CBO and GC, adapting “big pharma” playbook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBkSTZ2X1hUY0QtVkVNN3RsY2RwWnVMT0NhVkhybmoweXUyZWREbWxQQWNDdktiUzRCSk5lREUzZzJNWktfM3hfM0kyNnRicFJaaFk0?oc=5","date":"2022-03-07","type":"pipeline","source":"BioSpace","summary":"Three More Biopharma Companies Shuffle Executive Deck - BioSpace","headline":"Three More Biopharma Companies Shuffle Executive Deck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOeVp3ZDFBbk1ZcTlIWFRKLWxxdm4yOHJOdVN5SFRVcVlUcEloc3lrTWl5dFY1SGcwOTNnQVJxaFNnam9RZnl1bU9NT0gzbGlVV01UZ2NNY3liVEpfazlxUUJnZWhGaGgzOHRiSl9VT0JjRFQ4aXVkWGVrVU9xeXhURy1NWHVjLW9ic3ppNDNDemU1dHhyTWpFY00tMjQ1QjF0TnZkVl9RZTJTZw?oc=5","date":"2022-03-04","type":"pipeline","source":"The Business Journals","summary":"Covid drug hopeful turns to biotech vet who sold last company for $1 billlion - The Business Journals","headline":"Covid drug hopeful turns to biotech vet who sold last company for $1 billlion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxONFNjc0JKejNzazEyb1FBcWdUSXVJdDJyYXlidUlzRXFjX3dzUVJZQ3pUNnBOc01sR1VidWk0aGIxRGJoc19GWEI4S2lRc2lQeXBEMGFxUVg0RkQ1ZlVYeUstc3B6QlpRQmcyaFdPMzJtNzNXaEwwRkVTNzBMNmlBU3hSbVBZczRhOFFMSmpfajNfR1RnZFJkTVNDMnFBMUhsU3p5WDhoNnJMU2xVQnVFY1p6SkxnMmtuVGwxZ0lSME9rNmUxOXFhek9VNldYa1VSVS1VNXhOQWMzUThNT1VWUThqTmxkTWo2MjJGb1QtR0dMVVhWalIzOFcxeUh4UlVEdklWUGUxTFhXR1FDV28xMWw2ZjluUkVNSDlQZmtmU3RBWjFTMGotQm9Zbmk?oc=5","date":"2021-12-27","type":"pipeline","source":"GlobeNewswire","summary":"Pardes Biosciences Debuts as a Publicly Traded Company - GlobeNewswire","headline":"Pardes Biosciences Debuts as a Publicly Traded Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQRHgyTXdRM2J4VlE2eGExeEQtbFB3ZVZpbmhuNTByNUh5cEFvbkVHb1ozZDRTNFphdEZaM2J2S0Q4Vy1ySWlSQW82UzYtYUN0bDdzdjRZOWQ3UUVHeDU3aU9MMWt1VjRXeXg3S0xlZVEwcXlqRUNRcFhONThNNk9xcw?oc=5","date":"2021-09-07","type":"pipeline","source":"Fierce Biotech","summary":"SPAC Attack: The 10 biggest in biotech - Fierce Biotech","headline":"SPAC Attack: The 10 biggest in biotech","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}